123 lines
55 KiB
Text
123 lines
55 KiB
Text
<!DOCTYPE html>
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
|
|
<head>
|
|
<!-- For pinger, set start time and add meta elements. -->
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books">
|
|
<meta name="ncbi_pdid" content="book-part">
|
|
<meta name="ncbi_acc" content="NBK547936">
|
|
<meta name="ncbi_domain" content="livertox">
|
|
<meta name="ncbi_report" content="reader">
|
|
<meta name="ncbi_type" content="fulltext">
|
|
<meta name="ncbi_objectid" content="">
|
|
<meta name="ncbi_pcid" content="/NBK547936/?report=reader">
|
|
<meta name="ncbi_pagename" content="Enalapril - LiverTox - NCBI Bookshelf">
|
|
<meta name="ncbi_bookparttype" content="chapter">
|
|
<meta name="ncbi_app" content="bookshelf">
|
|
<!-- Logger end -->
|
|
|
|
<!--component id="Page" label="meta"/-->
|
|
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Enalapril - LiverTox - NCBI Bookshelf</title>
|
|
<meta charset="utf-8">
|
|
<meta name="apple-mobile-web-app-capable" content="no">
|
|
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
|
|
<meta name="jr-col-layout" content="auto">
|
|
<meta name="jr-prev-unit" content="/books/n/livertox/Emtricitabine/?report=reader">
|
|
<meta name="jr-next-unit" content="/books/n/livertox/Enasidenib/?report=reader">
|
|
<meta name="bk-toc-url" content="/books/n/livertox/?report=toc">
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
|
|
<meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]">
|
|
<meta name="citation_title" content="Enalapril">
|
|
<meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases">
|
|
<meta name="citation_date" content="2018/02/11">
|
|
<meta name="citation_pmid" content="31643271">
|
|
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK547936/">
|
|
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
|
|
<meta name="DC.Title" content="Enalapril">
|
|
<meta name="DC.Type" content="Text">
|
|
<meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases">
|
|
<meta name="DC.Date" content="2018/02/11">
|
|
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK547936/">
|
|
<meta name="description" content="Enalapril is an angiotensin-converting enzyme (ACE) inhibitor widely used in the therapy of hypertension and heart failure. Enalapril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.">
|
|
<meta name="og:title" content="Enalapril">
|
|
<meta name="og:type" content="book">
|
|
<meta name="og:description" content="Enalapril is an angiotensin-converting enzyme (ACE) inhibitor widely used in the therapy of hypertension and heart failure. Enalapril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.">
|
|
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK547936/">
|
|
<meta name="og:site_name" content="NCBI Bookshelf">
|
|
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png">
|
|
<meta name="twitter:card" content="summary">
|
|
<meta name="twitter:site" content="@ncbibooks">
|
|
<meta name="bk-non-canon-loc" content="/books/n/livertox/Enalapril/?report=reader">
|
|
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK547936/">
|
|
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&subset=latin" rel="stylesheet" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
|
|
<meta name="format-detection" content="telephone=no">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
|
|
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
|
|
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
|
|
<meta name="ncbi_phid" content="CE8B97177D7CAB6100000000009A0080.m_5">
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
|
|
<body>
|
|
<!-- Book content! -->
|
|
|
|
|
|
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK547936/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
|
|
<style type="text/css">.st0{fill:#939598;}</style>
|
|
<g>
|
|
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
|
|
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
|
|
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
|
|
</g>
|
|
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/livertox/Emtricitabine/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">Enalapril</div><div class="j">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]</div></div><div class="tail"><a href="/books/n/livertox/Enasidenib/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK547936/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK547936/&text=Enalapril"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/livertox/?report=reader">Title Information</a><a href="/books/n/livertox/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK547936/?report=classic">Switch to classic view</a><a href="/books/NBK547936/pdf/Bookshelf_NBK547936.pdf">PDF (109K)</a><a href="/books/NBK547936/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK547936%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8B97177D7CAB6100000000009A0080.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">✘</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">✘</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">◀</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">▶</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK547936_"><span class="title" itemprop="name">Enalapril</span></h1><p class="fm-aai"><a href="#_NBK547936_pubdet_">Publication Details</a></p></div></div><div class="body-content whole_rhythm" itemprop="text"><div id="Enalapril.OVERVIEW"><h2 id="_Enalapril_OVERVIEW_">OVERVIEW</h2><div id="Enalapril.Introduction"><h3>Introduction</h3><p>Enalapril is an angiotensin-converting enzyme (ACE) inhibitor widely used in the therapy of hypertension and heart failure. Enalapril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.</p></div><div id="Enalapril.Background"><h3>Background</h3><p>Enalapril (en al' a pril) was the second ACE inhibitor to be approved for use in the United States and is still widely used for therapy of hypertension and heart failure. Like other ACE inhibitors, enalapril inhibits the conversion of angiotensin I, a relatively inactive molecule, to angiotensin II which is the major mediator of vasoconstriction and volume expansion induced by the renin-angiotensin system. Other enzymes besides that which converts angiotensin I to II may also be inhibited, which may account for some of the side effects of the ACE inhibitors. Like many other ACE inhibitors, enalapril is a prodrug and must be hydrolyzed in the liver to its active carboxylic metabolite, enalaprilat. Enalapril was approved for use in the United States in 1985 and current indications include hypertension, symptomatic heart failure and prevention of progression of left ventricular dysfunction. Enalapril is available in 2.5, 5, 10 and 20 mg tablets in generic forms and under the trade name Vasotec. The typical initial oral dose of enalapril in adults is 2.5 to 5 mg once or twice daily, which can be increased to a maximum of 40 mg daily. Injectable formulations of enalaprilat, the active metabolic product of enalapril, are available in 1 and 2 mL vials of 1.25 mg/mL for intravenous administration. Enalapril is also available in fixed combinations with hydrochlorothiazide (generically and as Vaseretic) and with felodipine (Lexxel). Common side effects include dizziness, fatigue, headache, cough, gastrointestinal upset and skin rash. Rare, but potentially serious adverse events include hypersensitivity reactions, anaphylaxis and fetal or neonatal mortality.</p></div><div id="Enalapril.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>Enalapril, like other ACE inhibitors, has been associated with a low rate of serum aminotransferase elevations (<2%) that, in controlled trials, was no higher than with placebo therapy. These elevations were transient and rarely required dose modification. In addition, more than a dozen instances of clinically apparent acute liver injury have been reported with enalapril therapy. The onset is usually within 2 to 12 weeks of starting therapy and the serum enzyme pattern is typically cholestatic. In some instances, cholestasis has been prolonged and relapsing and associated with persistent elevations in serum alkaline phosphatase, suggestive of vanishing bile duct syndrome. Immunoallergic manifestations (rash, fever, eosinophilia) are infrequent and most patients do not develop autoantibodies. There have also been striking instances of enalapril liver injury with a hepatocellular pattern. These cases typically have a long latency (one or more years), some of which have been severe and fatal. The appearance of an acute liver injury more than a year after starting a medication is distinctly unusual, but has been described for several ACE inhibitors.</p><p>Likelihood score: B (likely but rare cause of clinically apparent liver injury).</p></div><div id="Enalapril.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>The cause of the minor serum aminotransferase elevations associated with enalapril is not known. The clinically apparent cases of hepatotoxicity due to enalapril are clearly idiosyncratic and likely due to a reaction to a metabolite. The instances of enalapril associated liver injury associated with a long latency may be due to a different mechanism. Enalapril is metabolized by the liver to enalaprilat, its active form, but further hepatic metabolism is minimal and enalapril has little interaction with the cytochrome P450 system.</p></div><div id="Enalapril.Outcome_and_Management"><h3>Outcome and Management</h3><p>Most instances of acute liver injury reported with enalapril use have been self limited, but severe and fatal instances have been reported as have cases of vanishing bile duct syndrome. Patients with severe enalapril induced acute liver injury should avoid use of other ACE inhibitors, although cross sensitivity to liver injury among the members of this class of agents has not always been shown.</p><p>References to the safety and potential hepatotoxicity of enalapril are given in the Overview section on the Angiotensin-Converting Enzyme (ACE) Inhibitors (Updated February 2018).</p><p>Drug Class: <a href="/books/n/livertox/AntihypertensiveAgen/?report=reader">Antihypertensive Agents</a>, <a href="/books/n/livertox/ACEinibitors/?report=reader">Angiotensin-Converting Enzyme Inhibitors</a></p></div></div><div id="Enalapril.CASE_REPORTS"><h2 id="_Enalapril_CASE_REPORTS_">CASE REPORTS</h2><div id="Enalapril.Case_1._Cholestatic_hepatitis_"><h3>Case 1. Cholestatic hepatitis due to enalapril.</h3><p>[Modified from: Todd P, Levison D, Farthing MJ. Enalapril-related cholestatic jaundice. J R Soc Med 1990; 83: 271-2. <a href="https://www.ncbi.nlm.nih.gov/pubmed/2342045" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PubMed Citation</a>]</p><p>A 67 year old woman was switched from atenolol to enalapril (15 mg daily) in combination with a diuretic (cyclopenthiazide 250 mcg daily) for better control of her essential hypertension. Six weeks later she developed dark urine, jaundice and pruritus. She had no history of liver disease, did not abuse alcohol and had no risk factors for acquiring viral hepatitis. On examination, she was jaundiced but had no fever, rash or peripheral manifestations of chronic liver disease. Laboratory testing showed a total serum bilirubin of 8.9 mg/dL, with moderate elevations of aminotransferase (AST 236 U/L) and alkaline phosphatase levels (437 U/L) (Table). There was no eosinophilia and the prothrombin time was normal. Tests for hepatitis A and B were negative as were autoantibodies. Abdominal ultrasound showed no evidence of biliary obstruction. A liver biopsy showed intrahepatic cholestasis typical of drug induced liver injury. Four days after admission, enalapril was stopped and she began to improve rapidly. When seen 3 months later, she was asymptomatic and laboratory values were normal.</p><div id="Enalapril.Key_Points1"><h4>Key Points</h4><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figEnalaprilT1"><a href="/books/NBK547936/table/Enalapril.T1/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figEnalaprilT1" rid-ob="figobEnalaprilT1"><img class="small-thumb" src="/books/NBK547936/table/Enalapril.T1/?report=thumb" src-large="/books/NBK547936/table/Enalapril.T1/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="Enalapril.T1"><a href="/books/NBK547936/table/Enalapril.T1/?report=objectonly" target="object" rid-ob="figobEnalaprilT1">Table</a></h4></div></div></div><div id="Enalapril.Laboratory_Values1"><h4>Laboratory Values</h4><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figEnalaprilT2"><a href="/books/NBK547936/table/Enalapril.T2/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figEnalaprilT2" rid-ob="figobEnalaprilT2"><img class="small-thumb" src="/books/NBK547936/table/Enalapril.T2/?report=thumb" src-large="/books/NBK547936/table/Enalapril.T2/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="Enalapril.T2"><a href="/books/NBK547936/table/Enalapril.T2/?report=objectonly" target="object" rid-ob="figobEnalaprilT2">Table</a></h4></div></div><p>* Values and dates in Table estimated from Figure 1.</p></div><div id="Enalapril.Comment1"><h4>Comment</h4><p>The patient developed a cholestatic hepatitis within 6 weeks of starting enalapril therapy and recovery was prompt once the medication was stopped. This is a typical history for enalapril induced acute liver injury. In rare instances of ACE inhibitor associated cholestatic hepatitis, jaundice and pruritus can be prolonged and progress to vanishing bile duct syndrome leading to cirrhosis and end stage liver disease. However, slow but eventually complete recovery is the more common outcome.</p></div></div><div id="Enalapril.Case_2._Cholestatic_hepatitis_"><h3>Case 2. Cholestatic hepatitis arising after 18 months of enalapril therapy.</h3><p>[Modified from a case in the database of the Drug-Induced Liver Injury Network]</p><p>An 83 year old man with hypertension and coronary artery disease had been taking enalapril and metoprolol for 18 months when he developed fatigue, anorexia, pruritus and jaundice. He had a history of jaundice in his teens which resolved completely. He had also been a moderately heavy drinker much of his life, but quit drinking alcohol 20 years previously. He had no history of drug hypersensitivity or reactions. His other medical problems included hypothyroidism for which he had taken levothyroxine for 7 years, hypercholesterolemia for which he had taken simvastatin for 7 years and fenofibrate for 6 months. On examination, he was jaundiced but had no fever or peripheral manifestations of chronic liver disease. Laboratory tests showed a bilirubin of 5.8 mg/dL, ALT 70 U/L and alkaline phosphatase of 369 U/L; these tests had been repeatedly normal during the previous six months. Tests for hepatitis A, B and C were negative. He had low levels of antinuclear antibody (1:80) and a slight elevation in serum immunoglobulin G (1,734 mg/dL: normal <1,700 mg/dL). Magnetic resonance cholangiopancreatography showed no evidence of gallstones or biliary obstruction. A liver biopsy showed intrahepatic cholestasis suggestive of drug induced liver injury. Simvastatin was stopped and his enalapril, metoprolol and fenofibrate were continued. His serum bilirubin and alkaline phosphatase remained elevated. Three months after onset of jaundice, enalapril was stopped and he rapidly improved, his pruritus resolving and bilirubin falling to normal within two weeks. Serum alkaline phosphatase improved more slowly and was still mildly elevated 6 months later.</p><div id="Enalapril.Key_Points2"><h4>Key Points</h4><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figEnalaprilT3"><a href="/books/NBK547936/table/Enalapril.T3/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figEnalaprilT3" rid-ob="figobEnalaprilT3"><img class="small-thumb" src="/books/NBK547936/table/Enalapril.T3/?report=thumb" src-large="/books/NBK547936/table/Enalapril.T3/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="Enalapril.T3"><a href="/books/NBK547936/table/Enalapril.T3/?report=objectonly" target="object" rid-ob="figobEnalaprilT3">Table</a></h4></div></div></div><div id="Enalapril.Laboratory_Values2"><h4>Laboratory Values</h4><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figEnalaprilT4"><a href="/books/NBK547936/table/Enalapril.T4/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figEnalaprilT4" rid-ob="figobEnalaprilT4"><img class="small-thumb" src="/books/NBK547936/table/Enalapril.T4/?report=thumb" src-large="/books/NBK547936/table/Enalapril.T4/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="Enalapril.T4"><a href="/books/NBK547936/table/Enalapril.T4/?report=objectonly" target="object" rid-ob="figobEnalaprilT4">Table</a></h4></div></div></div><div id="Enalapril.Comment2"><h4>Comment</h4><p>The patient developed a cholestatic hepatitis which was initially attributed to simvastatin. When he had not improved three months later, enalapril was stopped, and jaundice and pruritus improved within a few weeks. Serum ALT and alkaline phosphatase levels remained mildly elevated. Stopping fenofibrate appeared to have no effect. Eight months after stopping enalapril, the patient had no symptoms of liver disease but had mildly elevated serum enzymes, these tests having been repeatedly normal in the past. Had all medications been discontinued when he first developed jaundice, the role of enalapril versus simvastatin (or fenofibrate) would have been difficult to define. The long latency period (18 months) to onset of clinically apparent liver injury is uncommon, but has been described both for the ACE inhibitors such as enalapril and the statins such as simvastatin. The long latency associated cases of hepatotoxicity due to ACE inhibitors is typically, but not invariably, hepatocellular.</p></div></div></div><div id="Enalapril.PRODUCT_INFORMATION"><h2 id="_Enalapril_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><div id="Enalapril.BPI" class="box boxed-text-box whole_rhythm hide-overflow"><p>
|
|
<b>REPRESENTATIVE TRADE NAMES</b>
|
|
</p><p>Enalapril – Generic, Vasotec®</p><p>
|
|
<b>DRUG CLASS</b>
|
|
</p><p>Angiotensin-Converting Enzyme Inhibitors</p><p>
|
|
<a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Enalapril" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">COMPLETE LABELING</a>
|
|
</p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div></div><div id="Enalapril.CHEMICAL_FORMULA_AND_STRUCTURE"><h2 id="_Enalapril_CHEMICAL_FORMULA_AND_STRUCTURE_">CHEMICAL FORMULA AND STRUCTURE</h2><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figEnalaprilT5"><a href="/books/NBK547936/table/Enalapril.T5/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figEnalaprilT5" rid-ob="figobEnalaprilT5"><img class="small-thumb" src="/books/NBK547936/table/Enalapril.T5/?report=thumb" src-large="/books/NBK547936/table/Enalapril.T5/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="Enalapril.T5"><a href="/books/NBK547936/table/Enalapril.T5/?report=objectonly" target="object" rid-ob="figobEnalaprilT5">Table</a></h4></div></div></div><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK547936_pubdet_">Publication Details</h2><h3>Publication History</h3><p class="small">Last Update: <span itemprop="dateModified">February 11, 2018</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div></div><h3>Publisher</h3><p><a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&targetsite=external&targetcat=link&targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>, Bethesda (MD)</p><h3>NLM Citation</h3><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Enalapril. [Updated 2018 Feb 11].<span class="bk_cite_avail"></span></p></div><div class="small-screen-prev"><a href="/books/n/livertox/Emtricitabine/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/livertox/Enasidenib/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="table-wrap" id="figobEnalaprilT1"><div id="Enalapril.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547936/table/Enalapril.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Enalapril.T1_lrgtbl__"><table><thead><tr><th id="hd_h_Enalapril.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Medication:</th><td rowspan="1" colspan="1" style="vertical-align:top;">Enalapril (15 mg daily)</td></tr></thead><tbody><tr><th headers="hd_h_Enalapril.T1_1_1_1_1" id="hd_b_Enalapril.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</th><td headers="hd_b_Enalapril.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Cholestatic (R=1.4)</td></tr><tr><th headers="hd_h_Enalapril.T1_1_1_1_1" id="hd_b_Enalapril.T1_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">Severity:</th><td headers="hd_b_Enalapril.T1_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">3+ (jaundice, hospitalization)</td></tr><tr><th headers="hd_h_Enalapril.T1_1_1_1_1" id="hd_b_Enalapril.T1_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;">Latency:</th><td headers="hd_b_Enalapril.T1_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;">6 weeks to jaundice</td></tr><tr><th headers="hd_h_Enalapril.T1_1_1_1_1" id="hd_b_Enalapril.T1_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</th><td headers="hd_b_Enalapril.T1_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">Partial after 2 weeks, complete after 12 weeks</td></tr><tr><th headers="hd_h_Enalapril.T1_1_1_1_1" id="hd_b_Enalapril.T1_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</th><td headers="hd_b_Enalapril.T1_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Cyclopenthiazide</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobEnalaprilT2"><div id="Enalapril.T2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547936/table/Enalapril.T2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Enalapril.T2_lrgtbl__"><table><thead><tr><th id="hd_h_Enalapril.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Time After Starting</th><th id="hd_h_Enalapril.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Days After Stopping</th><th id="hd_h_Enalapril.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">ALT* (U/L)</th><th id="hd_h_Enalapril.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Alk P* (U/L)</th><th id="hd_h_Enalapril.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Bilirubin* (mg/dL)</th><th id="hd_h_Enalapril.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Enalapril.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">6 weeks</td><td headers="hd_h_Enalapril.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Enalapril.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">236</td><td headers="hd_h_Enalapril.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">437</td><td headers="hd_h_Enalapril.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">8.9</td><td headers="hd_h_Enalapril.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Admission for jaundice</td></tr><tr><td headers="hd_h_Enalapril.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">6.5 weeks</td><td headers="hd_h_Enalapril.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Enalapril.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">110</td><td headers="hd_h_Enalapril.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">505</td><td headers="hd_h_Enalapril.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">6.4</td><td headers="hd_h_Enalapril.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Enalapril stopped</td></tr><tr><td headers="hd_h_Enalapril.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">7 weeks</td><td headers="hd_h_Enalapril.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 days</td><td headers="hd_h_Enalapril.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">65</td><td headers="hd_h_Enalapril.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">490</td><td headers="hd_h_Enalapril.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">3.8</td><td headers="hd_h_Enalapril.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">8 weeks</td><td headers="hd_h_Enalapril.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">10 days</td><td headers="hd_h_Enalapril.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">25</td><td headers="hd_h_Enalapril.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">205</td><td headers="hd_h_Enalapril.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.9</td><td headers="hd_h_Enalapril.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Hospital discharge</td></tr><tr><td headers="hd_h_Enalapril.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">5 months</td><td headers="hd_h_Enalapril.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 months</td><td headers="hd_h_Enalapril.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">20</td><td headers="hd_h_Enalapril.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">75</td><td headers="hd_h_Enalapril.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.6</td><td headers="hd_h_Enalapril.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T2_1_1_1_1 hd_h_Enalapril.T2_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;">
|
|
<b>Normal Values</b>
|
|
</td><td headers="hd_h_Enalapril.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<b><40</b>
|
|
</td><td headers="hd_h_Enalapril.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<b><100</b>
|
|
</td><td headers="hd_h_Enalapril.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<b><1.2</b>
|
|
</td><td headers="hd_h_Enalapril.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobEnalaprilT3"><div id="Enalapril.T3" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547936/table/Enalapril.T3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Enalapril.T3_lrgtbl__"><table><thead><tr><th id="hd_h_Enalapril.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Medication:</th><td rowspan="1" colspan="1" style="vertical-align:top;">Enalapril (dose not provided)</td></tr></thead><tbody><tr><th headers="hd_h_Enalapril.T3_1_1_1_1" id="hd_b_Enalapril.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</th><td headers="hd_b_Enalapril.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Cholestatic (R=0.6)</td></tr><tr><th headers="hd_h_Enalapril.T3_1_1_1_1" id="hd_b_Enalapril.T3_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">Severity:</th><td headers="hd_b_Enalapril.T3_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">3+ (jaundice, hospitalization)</td></tr><tr><th headers="hd_h_Enalapril.T3_1_1_1_1" id="hd_b_Enalapril.T3_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;">Latency:</th><td headers="hd_b_Enalapril.T3_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;">16 months</td></tr><tr><th headers="hd_h_Enalapril.T3_1_1_1_1" id="hd_b_Enalapril.T3_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</th><td headers="hd_b_Enalapril.T3_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">Partial after 2 weeks</td></tr><tr><th headers="hd_h_Enalapril.T3_1_1_1_1" id="hd_b_Enalapril.T3_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</th><td headers="hd_b_Enalapril.T3_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Simvastatin, fenofibrate, metoprolol, synthroid</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobEnalaprilT4"><div id="Enalapril.T4" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547936/table/Enalapril.T4/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Enalapril.T4_lrgtbl__"><table><thead><tr><th id="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Time After Starting</th><th id="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Weeks After Stopping</th><th id="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">ALT (U/L)</th><th id="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Alk P (U/L)</th><th id="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Bilirubin (mg/dL)</th><th id="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Pre</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">25</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">104</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.5</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Enalapril started</td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">12 months</td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">24</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">82</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.5</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Fenofibrate started</td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">14 months</td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">15</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">114</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.4</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">16 months</td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">27</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">94</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.4</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">18 months</td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Pre</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">70</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">369</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">5.8</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Simvastatin stopped</td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">19 months</td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">51</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">425</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">8.7</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">20 months</td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">97</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">272</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">4.7</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">21 months</td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">91</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">578</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">7.7</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Enalapril stopped</td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 days</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">48</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">511</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.9</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">10 days</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">40</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">423</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.7</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Fenofibrate stopped</td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">2 weeks</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">55</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">356</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.6</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 weeks</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">44</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">314</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.6</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">22 months</td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">5 weeks</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">71</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">285</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.7</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">6 weeks</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">42</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">211</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.7</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">23 months</td><td headers="hd_h_Enalapril.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">8 weeks</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">52</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">228</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.5</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Enalapril.T4_1_1_1_1 hd_h_Enalapril.T4_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;">
|
|
<b>Normal Values</b>
|
|
</td><td headers="hd_h_Enalapril.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<b><40</b>
|
|
</td><td headers="hd_h_Enalapril.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<b><100</b>
|
|
</td><td headers="hd_h_Enalapril.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<b><1.2</b>
|
|
</td><td headers="hd_h_Enalapril.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div></article><article data-type="boxed-text" id="figobEnalaprilBPI"><div id="Enalapril.BPI" class="box boxed-text-box whole_rhythm hide-overflow"><p>
|
|
<b>REPRESENTATIVE TRADE NAMES</b>
|
|
</p><p>Enalapril – Generic, Vasotec®</p><p>
|
|
<b>DRUG CLASS</b>
|
|
</p><p>Angiotensin-Converting Enzyme Inhibitors</p><p>
|
|
<a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Enalapril" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">COMPLETE LABELING</a>
|
|
</p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div></article><article data-type="table-wrap" id="figobEnalaprilT5"><div id="Enalapril.T5" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547936/table/Enalapril.T5/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Enalapril.T5_lrgtbl__"><table><thead><tr><th id="hd_h_Enalapril.T5_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_Enalapril.T5_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NUMBER</th><th id="hd_h_Enalapril.T5_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Enalapril.T5_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Enalapril.T5_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Enalapril</td><td headers="hd_h_Enalapril.T5_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/substance/135012773" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">75847-73-3</a>
|
|
</td><td headers="hd_h_Enalapril.T5_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C20-H28-N2-O5</td><td headers="hd_h_Enalapril.T5_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<div class="graphic"><img src="/books/NBK547936/bin/Enalapril_Structure.jpg" alt="Enalapril Chemical Structure" /></div>
|
|
</td></tr></tbody></table></div></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script></div></div>
|
|
|
|
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal104 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
|
|
</html>
|